Sotac Pharmaceuticals Limited (NSE:SOTAC)

Sotac Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	814.02	969.87	1,038	774.83	731.52	488.43
Other Revenue	32.7	32.7	1.35	-	-	-
Revenue	846.72	1,003	1,040	774.83	731.52	488.43
Revenue Growth (YoY)	-19.27%	-3.57%	34.18%	5.92%	49.77%	70.76%
Cost of Revenue	510.7	683.11	796.12	572.69	559.77	393.92
Gross Profit	336.02	319.45	243.53	202.14	171.75	94.51
Selling, General & Admin	40.64	35.25	40.36	42.93	30.04	31.78
Other Operating Expenses	132.54	114.6	114.96	83.31	61.93	48.19
Operating Expenses	223.68	188.21	186.33	149.01	103.24	105.9
Operating Income	112.34	131.25	57.2	53.13	68.51	-11.39
Interest Expense	-30.96	-22.33	-15.51	-19.02	-5.02	-9.96
Interest & Investment Income	5.57	5.57	1.82	0.46	0.48	0.74
Currency Exchange Gain (Loss)	-	-	-0.07	-	-	-
Other Non Operating Income (Expenses)	32.39	-3.48	-1.81	-1.11	1.33	0.04
EBT Excluding Unusual Items	119.33	111.01	41.63	33.47	65.31	-20.57
Gain (Loss) on Sale of Investments	-	-	-	-	-18.36	-
Gain (Loss) on Sale of Assets	0.19	0.19	-	-	-	-
Other Unusual Items	-0.02	-0	-2.34	5.8	-	-
Pretax Income	119.51	111.2	39.64	39.27	46.95	-20.57
Income Tax Expense	18.55	18.44	3.85	16.41	18.16	3.09
Earnings From Continuing Operations	100.96	92.75	35.79	22.86	28.79	-23.65
Minority Interest in Earnings	-15.36	-12.49	7.02	5.93	-	-
Net Income	85.6	80.27	42.81	28.79	28.79	-23.65
Net Income to Common	85.6	80.27	42.81	28.79	28.79	-23.65
Net Income Growth	91.93%	87.48%	48.69%	0.02%	-	-
Shares Outstanding (Basic)	11	11	11	8	8	8
Shares Outstanding (Diluted)	11	11	11	8	8	8
Shares Change (YoY)	0.05%	0.67%	36.35%	-	-	132.16%
EPS (Basic)	7.74	7.26	3.90	3.58	3.58	-2.94
EPS (Diluted)	7.74	7.26	3.90	3.58	3.58	-2.94
EPS Growth	91.77%	86.15%	9.04%	0.02%	-	-
Free Cash Flow	-134.81	-213.47	-338.65	-8.57	28.46	-34.68
Free Cash Flow Per Share	-12.19	-19.32	-30.85	-1.06	3.54	-4.31
Dividend Per Share	-	0.100	-	-	2.000	-
Gross Margin	39.68%	31.86%	23.42%	26.09%	23.48%	19.35%
Operating Margin	13.27%	13.09%	5.50%	6.86%	9.37%	-2.33%
Profit Margin	10.11%	8.01%	4.12%	3.72%	3.94%	-4.84%
Free Cash Flow Margin	-15.92%	-21.29%	-32.57%	-1.11%	3.89%	-7.10%
EBITDA	162.79	169.54	88.16	75.89	79.77	14.54
EBITDA Margin	19.23%	16.91%	8.48%	9.79%	10.90%	2.98%
D&A For EBITDA	50.45	38.3	30.95	22.76	11.26	25.93
EBIT	112.34	131.25	57.2	53.13	68.51	-11.39
EBIT Margin	13.27%	13.09%	5.50%	6.86%	9.37%	-2.33%
Effective Tax Rate	15.52%	16.59%	9.70%	41.78%	38.68%	-
Revenue as Reported	888.86	1,009	1,043	778.33	733.7	489.5
Advertising Expenses	-	3.15	0.05	0.3	0.02	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.